Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

Analog 23 is a promising compound for prostate cancer treatment.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

Optimized film improves finasteride skin absorption and treatment efficiency.

Pranlukast and mirabegron may work as new diabetes drugs.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

TA-Ado effectively promotes hair growth and reduces hair loss.

Finasteride may affect PNMT, causing side effects.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

The document does not give specific results for hair loss treatment effectiveness.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

A new method to make Finasteride is more cost-effective and yields 16%.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.